loadpatents
name:-0.013401031494141
name:-0.011291027069092
name:-0.00061702728271484
Vigne; Emmanuelle Patent Filings

Vigne; Emmanuelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vigne; Emmanuelle.The latest application filed is for "targeted adenovirus vectors for delivery of heterologous genes".

Company Profile
0.10.10
  • Vigne; Emmanuelle - Ivry Sur Seine FR
  • Vigne; Emmanuelle - L'Hay-Les-Roses FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
Grant 7,033,826 - Perricaudet , et al. April 25, 2
2006-04-25
Targeted adenovirus vectors for delivery of heterologous genes
App 20060002893 - Vigne; Emmanuelle ;   et al.
2006-01-05
Targeted adenovirus vectors for delivery of heterologous genes
Grant 6,911,199 - Vigne , et al. June 28, 2
2005-06-28
Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)
App 20050069523 - Horellou, Philippe ;   et al.
2005-03-31
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
App 20040224409 - Pradier, Laurent ;   et al.
2004-11-11
Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
Grant RE38,556 - Benoit , et al. July 13, 2
2004-07-13
Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)
Grant 6,685,934 - Mallet , et al. February 3, 2
2004-02-03
Targeted adenovirus vectors for delivery of heterologous genes
App 20030143209 - Vigne, Emmanuelle ;   et al.
2003-07-31
Defective adenovirus vectors and use thereof in gene therapy
App 20030096787 - Perricaudet, Michel ;   et al.
2003-05-22
Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
App 20030039634 - Perricaudet, Michel ;   et al.
2003-02-27
Method for producing recombinant virus
App 20030022356 - Leblois-Prehaud, Helene ;   et al.
2003-01-30
Recombinant Adenoviruses Containing An Inducible Promoter Controlling A Gene Of Viral Origin
App 20020098165 - PERRICAUDET, MICHEL ;   et al.
2002-07-25
Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin
Grant 6,420,170 - Perricaudet , et al. July 16, 2
2002-07-16
Method for producing recombinant virus
Grant 6,387,670 - Leblois-Prehaud , et al. May 14, 2
2002-05-14
Recombinant Adenoviruses Coding For Glial-derived Cell Neurotrophic Factor (gdnf)
App 20020031493 - HORELLOU, PHILIPPE ;   et al.
2002-03-14
Recombinant Viruses Coding For A Glutamate Decarboxylase (gad) Activity
App 20020028212 - GEOFFROY, MARIE-CLAUDE ;   et al.
2002-03-07
Adenoviral vectors of canine origin
Grant 6,294,377 - Haddada , et al. September 25, 2
2001-09-25
Cells for the production of recombinant adenoviruses
Grant 6,127,175 - Vigne , et al. October 3, 2
2000-10-03
Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
Grant 6,033,885 - Latta , et al. March 7, 2
2000-03-07
Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
Grant 5,866,551 - Benoit , et al. February 2, 1
1999-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed